OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Orexin-1 Receptor-Cannabinoid CB1 Receptor Heterodimerization Results in Both Ligand-dependent and -independent Coordinated Alterations of Receptor Localization and Function
James Ellis, John D. Pediani, Meritxell Canals, et al.
Journal of Biological Chemistry (2006) Vol. 281, Iss. 50, pp. 38812-38824
Open Access | Times Cited: 219

Showing 1-25 of 219 citing articles:

International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1and CB2
Roger G. Pertwee, A­llyn C. Howlett, Mary E. Abood, et al.
Pharmacological Reviews (2010) Vol. 62, Iss. 4, pp. 588-631
Open Access | Times Cited: 1528

Endocannabinoid-Mediated Control of Synaptic Transmission
Masanobu Kano, Takako Ohno‐Shosaku, Yuki Hashimotodani, et al.
Physiological Reviews (2009) Vol. 89, Iss. 1, pp. 309-380
Closed Access | Times Cited: 1429

Seven Transmembrane Receptors as Shapeshifting Proteins: The Impact of Allosteric Modulation and Functional Selectivity on New Drug Discovery
Terry Kenakin, Laurence J. Miller
Pharmacological Reviews (2010) Vol. 62, Iss. 2, pp. 265-304
Open Access | Times Cited: 559

Multiple Functions of Endocannabinoid Signaling in the Brain
István Katona, Tamás F. Freund
Annual Review of Neuroscience (2012) Vol. 35, Iss. 1, pp. 529-558
Open Access | Times Cited: 556

Diencephalic and brainstem mechanisms in migraine
Simon Akerman, Philip R. Holland, Peter J. Goadsby
Nature reviews. Neuroscience (2011) Vol. 12, Iss. 10, pp. 570-584
Closed Access | Times Cited: 505

Emerging paradigms in GPCR allostery: implications for drug discovery
Denise Wootten, Arthur Christopoulos, Patrick M. Sexton
Nature Reviews Drug Discovery (2013) Vol. 12, Iss. 8, pp. 630-644
Closed Access | Times Cited: 445

Review of the Endocannabinoid System
Hui‐Chen Lu, Ken Mackie
Biological Psychiatry Cognitive Neuroscience and Neuroimaging (2020) Vol. 6, Iss. 6, pp. 607-615
Open Access | Times Cited: 362

G protein‐coupled receptor hetero‐dimerization: contribution to pharmacology and function
Graeme Milligan
British Journal of Pharmacology (2009) Vol. 158, Iss. 1, pp. 5-14
Open Access | Times Cited: 314

Signal transduction of the CB1 cannabinoid receptor
Gábor Turu, László Hunyady
Journal of Molecular Endocrinology (2009) Vol. 44, Iss. 2, pp. 75-85
Open Access | Times Cited: 305

Cannabinoids and Cytochrome P450 Interactions
Ondřej Zendulka, Gabriela Dovrtělová, Kristýna Nosková, et al.
Current Drug Metabolism (2016) Vol. 17, Iss. 3, pp. 206-226
Closed Access | Times Cited: 244

The Orexin/Receptor System: Molecular Mechanism and Therapeutic Potential for Neurological Diseases
Chunmei Wang, Qinqin Wang, Bingyuan Ji, et al.
Frontiers in Molecular Neuroscience (2018) Vol. 11
Open Access | Times Cited: 163

Cardiotoxic effects of common and emerging drugs: role of cannabinoid receptors
Yi-Ming Bo, Xin Zhao, Liliang Li
Clinical Science (2024) Vol. 138, Iss. 6, pp. 413-434
Closed Access | Times Cited: 22

Allostery at G Protein-Coupled Receptor Homo- and Heteromers: Uncharted Pharmacological Landscapes
Nicola J. Smith, Graeme Milligan
Pharmacological Reviews (2010) Vol. 62, Iss. 4, pp. 701-725
Open Access | Times Cited: 246

An introduction to the endocannabinoid system: from the early to the latest concepts
Luciano De Petrocellis, Vincenzo Di Marzo
Best Practice & Research Clinical Endocrinology & Metabolism (2009) Vol. 23, Iss. 1, pp. 1-15
Closed Access | Times Cited: 237

Multiple roles for orexin/hypocretin in addiction
Stephen V. Mahler, Rachel J. Smith, David E. Moorman, et al.
Progress in brain research (2012), pp. 79-121
Open Access | Times Cited: 211

Functionally selective cannabinoid receptor signalling: Therapeutic implications and opportunities
Barbara Bosier, Giulio G. Muccioli, Emmanuel Hermans, et al.
Biochemical Pharmacology (2010) Vol. 80, Iss. 1, pp. 1-12
Closed Access | Times Cited: 181

Orexin/hypocretin receptor signalling cascades
Jyrki P. Kukkonen, Christopher S. Leonard
British Journal of Pharmacology (2013) Vol. 171, Iss. 2, pp. 314-331
Open Access | Times Cited: 180

Endocannabinoid functions controlling neuronal specification during brain development
Tibor Harkany, Erik Keimpema, Klaudia Barabás, et al.
Molecular and Cellular Endocrinology (2008) Vol. 286, Iss. 1-2, pp. S84-S90
Open Access | Times Cited: 171

The endocannabinoid system as a link between homoeostatic and hedonic pathways involved in energy balance regulation
Vincenzo Di Marzo, Alessia Ligresti, Luigia Cristino
International Journal of Obesity (2009) Vol. 33, Iss. S2, pp. S18-S24
Closed Access | Times Cited: 166

The Year In G Protein-Coupled Receptor Research
Robert P. Millar, Claire Newton
Molecular Endocrinology (2009) Vol. 24, Iss. 1, pp. 261-274
Open Access | Times Cited: 164

Allosteric modulation of heterodimeric G-protein-coupled receptors
Graeme Milligan, Nicola J. Smith
Trends in Pharmacological Sciences (2007) Vol. 28, Iss. 12, pp. 615-620
Closed Access | Times Cited: 163

Endocannabinoid signalling: has it got rhythm?
Linda K. Vaughn, Gerene M. Denning, Kara L. Stuhr, et al.
British Journal of Pharmacology (2010) Vol. 160, Iss. 3, pp. 530-543
Open Access | Times Cited: 162

Hetero-oligomerization of CCR2, CCR5, and CXCR4 and the Protean Effects of “Selective” Antagonists
Denis Sohy, Hideaki Yano, Patricia de Nadaı̈, et al.
Journal of Biological Chemistry (2009) Vol. 284, Iss. 45, pp. 31270-31279
Open Access | Times Cited: 155

MT1 and MT2 Melatonin Receptors: Ligands, Models, Oligomers, and Therapeutic Potential
Darius P. Zlotos, Ralf Jockers, Erika Cecon, et al.
Journal of Medicinal Chemistry (2013) Vol. 57, Iss. 8, pp. 3161-3185
Closed Access | Times Cited: 151

Orexin receptors: Multi-functional therapeutic targets for sleeping disorders, eating disorders, drug addiction, cancers and other physiological disorders
Tian‐Rui Xu, Yang Yang, Richard J. Ward, et al.
Cellular Signalling (2013) Vol. 25, Iss. 12, pp. 2413-2423
Closed Access | Times Cited: 142

Page 1 - Next Page

Scroll to top